Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sequenom slumps after USPTO withdraws issuance of patent
The Fly on the Wall
Monday, December 17, 2012 - 1:26pm
tags:
patents, Sequenom
Can Regeneron Continue To Generate Profits?
Seeking Alpha
Monday, December 17, 2012 - 1:26pm
tags:
Regeneron
Orexigen: Is Contrave The Long-Term Winner In The Anti-Obesity Drug Wars?
Seeking Alpha
Monday, December 17, 2012 - 1:22pm
tags:
Orexigen, obesity, Contrave
Vivus shares jump on strong growth in Qsymia prescriptions
Reuters
Monday, December 17, 2012 - 1:21pm
tags:
Vivus, Qsymia, obesity
Teva Enters South Korean Drug Market in Bid to Grow in East Asia
Bloomberg
Monday, December 17, 2012 - 1:14pm
tags:
Teva, South Korea, Asia, Handok Pharmaceuticals
Gilead, Abbott should benefit from first mover HCV advantage, says Wells Fargo
Yahoo/Fly on the Wall
Monday, December 17, 2012 - 1:13pm
tags:
Gilead, Abbott Labs, hepatitis C
We See Opportunities for New Abbott to Raise Profitability
Yahoo/Morningstar
Monday, December 17, 2012 - 1:12pm
tags:
Abbott Labs, AbbVie
Merck CEO: Health Care Beyond the Fiscal Cliff Requires Structural Changes
Forbes
Monday, December 17, 2012 - 12:21pm
tags:
Kenneth Frazier, Pharma CEO, Merck
Tranzyme stops mid-stage study after drug fails
Yahoo/AP
Monday, December 17, 2012 - 12:16pm
tags:
Tranzyme, diabetic gastroparesis, TZP-102
OncoSec Looking For A Rich Uncle
Seeking Alpha
Monday, December 17, 2012 - 10:04am
tags:
OncoSec, Celsion
4 Stories to Watch This Week in the Health-Care Sector
Motley Fool
Monday, December 17, 2012 - 9:39am
tags:
FDA, Hemispherx Biopharma, Ampligen, Alexza, Adasuve, Neogen, Life Technologies, Qiagen
It's Hard to Make Money When FDA Approvals Are Priced In
Motley Fool
Monday, December 17, 2012 - 9:31am
tags:
FDA, drug approvals, Ariad Pharmaceuticals, Novartis, Dendreon, Medivation, Bayer, ONYX Pharmaceuticals, Otsuka, Bristol-Myers Squibb
Profiting From SCOTUS and Big Pharma: Part 2
Motley Fool
Sunday, December 16, 2012 - 11:02am
tags:
legal
Investor Enthusiasm Wanes For Obesity Drug Companies
Seeking Alpha
Sunday, December 16, 2012 - 11:01am
tags:
weight loss, obesity, Arena Pharmaceuticals, Belviq, Vivus, Qsymia
China Biotech In Review: China Leads Emerging Countries Pharma M&A
Seeking Alpha
Sunday, December 16, 2012 - 10:59am
tags:
Sinopharm, Fosun Pharmaceutical, Delmar Pharma, Mauna Kea Technologies, Veridex, JNJ
Is Eli Lilly on a Fruitless Quest? (video)
Motley Fool
Sunday, December 16, 2012 - 10:57am
tags:
Eli Lilly, Alzheimer's disease
3 Keys From Avanir's Quarterly Results
Motley Fool
Sunday, December 16, 2012 - 10:56am
tags:
Avanir
Has Geron Become the Perfect Stock?
Motley Fool
Sunday, December 16, 2012 - 10:55am
tags:
Geron
Biotech Under The Electron Microscope: What's In The Pipeline And Lessons To Be Learned
Seeking Alpha
Sunday, December 16, 2012 - 10:55am
tags:
Galena Biopharma, Advanced Cell Technology, Northwest Biotherapeutics, Neuralstem, Dendreon
Don't Get Too Worked Up Over Cambrex Corporation's Earnings
Motley Fool
Sunday, December 16, 2012 - 10:53am
tags:
Cambrex

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.